Alignment Healthcare, Inc. - Common Stock (ALHC)
CUSIP: 01625V104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 203,558,762
- Total 13F shares
- 168,001,667
- Share change
- +4,068,997
- Total reported value
- $1,313,040,967
- Put/Call ratio
- 8.5%
- Price per share
- $7.82
- Number of holders
- 114
- Value change
- +$35,275,143
- Number of buys
- 67
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 01625V104?
CUSIP 01625V104 identifies ALHC - Alignment Healthcare, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01625V104:
Top shareholders of ALHC - Alignment Healthcare, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
30%
|
60,993,323
|
$302,526,882 | — | 31 Mar 2024 | |
| WARBURG PINCUS LLC |
3/4/5
13F
|
Director, 10%+ Owner · Company |
8.8%
from 13F
|
17,922,779
|
$151,626,710 | — | 20 Sep 2022 | |
| Warburg Pincus Partners GP LLC |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,922,779
|
$151,626,710 | — | 20 Sep 2022 | |
| FMR LLC |
13F
|
Company |
8.3%
|
16,989,070
|
$84,265,787 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
9,239,472
|
$45,827,782 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
4.1%
|
8,304,142
|
$41,189,000 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.1%
|
8,270,697
|
$41,022,657 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.6%
|
7,393,982
|
$36,674,151 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.9%
|
5,982,907
|
$29,675,218 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.4%
|
4,866,764
|
$24,139,149 | — | 31 Mar 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.4%
|
2,920,836
|
$14,487,347 | — | 31 Mar 2024 | |
| Donald S. Furman |
3/4/5
|
Chief Clinical Officer |
—
class O/S missing
|
1,533,399
|
$12,972,556 | — | 15 Aug 2023 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
2,107,459
|
$10,452,997 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
2,085,396
|
$10,345,071 | — | 31 Mar 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.99%
|
2,022,736
|
$10,032,771 | — | 31 Mar 2024 | |
| Dinesh M. Kumar |
3/4/5
|
Chief Med & Operating Officer |
—
class O/S missing
|
1,088,651
|
$9,209,987 | — | 29 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.8%
|
1,632,467
|
$8,097,036 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
1,596,922
|
$7,920,733 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.66%
|
1,340,800
|
$6,650,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
768,105
|
$3,809,801 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
761,508
|
$3,777,080 | — | 31 Mar 2024 | |
| Richard A. Cross |
3/4/5
|
SVP, General Counsel |
—
class O/S missing
|
393,460
|
$3,328,672 | — | 29 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
477,850
|
$2,370,136 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.21%
|
433,975
|
$2,152,516 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.21%
|
430,975
|
$2,137,636 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
365,599
|
$1,813,370 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.17%
|
345,478
|
$1,713,571 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.17%
|
340,000
|
$1,686,400 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
323,638
|
$1,605,244 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.16%
|
315,629
|
$1,565,520 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
299,903
|
$1,487,519 | — | 31 Mar 2024 | |
| Melinda Michele Kimbro |
3/4/5
|
Chief People Officer |
—
class O/S missing
|
175,439
|
$1,484,214 | — | 05 Jul 2023 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.15%
|
295,768
|
$1,467,009 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
291,731
|
$1,446,987 | — | 31 Mar 2024 | |
| Rajesh Shrestha |
3/4/5
|
Pres., New Markets & CBO |
—
class O/S missing
|
170,220
|
$1,440,061 | — | 31 Mar 2022 | |
| Blue Trust, Inc. |
13F
|
Company |
0.13%
|
256,452
|
$1,272,002 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
204,200
|
$1,012,832 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
202,065
|
$1,002,242 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
185,076
|
$917,977 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
181,170
|
$898,603 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
167,307
|
$829,843 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
161,954
|
$803,292 | — | 31 Mar 2024 | |
| Ally Financial Inc. |
13F
|
Company |
0.07%
|
151,302
|
$750,458 | — | 31 Mar 2024 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.07%
|
142,827
|
$708,422 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.07%
|
142,730
|
$707,940 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
139,021
|
$689,544 | — | 31 Mar 2024 | |
| Thomas J. Carella |
3/4/5
|
Director |
—
class O/S missing
|
124,478
|
$676,924 | — | 13 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.06%
|
124,913
|
$619,568 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
121,213
|
$601,208 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.06%
|
119,133
|
$590,900 | — | 31 Mar 2024 |
Institutional Holders of Alignment Healthcare, Inc. - Common Stock (ALHC) as of Q2 2024
As of 30 Jun 2024,
Alignment Healthcare, Inc. - Common Stock (ALHC) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
168,001,667 shares.
The largest 10 holders included
GENERAL ATLANTIC, L.P., WARBURG PINCUS LLC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, Durable Capital Partners LP, and Hood River Capital Management LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
126
Q2 2024 holders
114
Holder diff
-12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.